PressOctober 3, 2022 Silo Pharma Initiates FDA Pre-Investigational New Drug Package for Time-Released Ketamine Technology
PressOctober 1, 2022 Core One Labs Announces Breakthrough with Proprietary Isolation and Purification Method of Psilocybin from Mushrooms; Prepares Patent Application
PressOctober 1, 2022 Silo Pharma Announces Closing of $5.75 Million Public Offering of Common Stock, Nasdaq Listing, and Full Exercise of Underwriter’s Over-Allotment Option
PressSeptember 30, 2022 MindMed Board is Trippin’: Significant Investor Calls for Termination of Highly Dilutive Equity Offering and Pledges to Hold Board and Management Accountable through Activist Campaign
PressSeptember 30, 2022 Supermind Platforms, Inc Acquires Psychedelics.com and Closes Pre-Seed Financing
PressSeptember 30, 2022 Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting
PressSeptember 30, 2022 PharmaTher Provides Business Highlights and Releases Audited Annual Financials for Fiscal Year Ended May 31, 2022
PressSeptember 29, 2022 Nova Mentis Psilocybin Microdose Capsule Formulation to be Submitted in Health Canada Phase 2A Clinical Trial Application
PressSeptember 29, 2022 Biomind and Queen’s University of Belfast Receive Controlled Substances License to Commence the Production of a Novel Transdermal Drug Delivery System
PressSeptember 29, 2022 Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer
Market ResearchSeptember 29, 2022 The MindMed Chronicles: A Conversation with Jake Freeman of Freeman Capital
PressSeptember 28, 2022 Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
PressSeptember 28, 2022 atai Life Sciences Announces Initiation of Phase 1 Trial for its MDMA Derivative, EMP-01
PressSeptember 28, 2022 Silo Wellness Executes Definitive Agreement to Acquire Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio
PressSeptember 28, 2022 Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds
BlogSeptember 28, 2022 Jordan Tishler is a Physician, Educator, and Patient Advocate – Podcast Episode #19
BlogSeptember 28, 2022 What are the Concerns With Self-Administering Psychedelics?: Mindshifting Moments #12
